Related Experiment Videos

Necrotizing pyomyositis caused by Mycobacterium avium complex in a patient with AIDS

G Diego Miralles, Z Bregman

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

|May 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effects of ritonavir-boosted darunavir vs. ritonavir-boosted atazanavir on lipid and glucose parameters in HIV-negative, healthy volunteers.

HIV medicine·2009

Efficacy of once-daily darunavir/ritonavir 800/100 mg in HIV-infected, treatment-experienced patients with no baseline resistance-associated mutations to darunavir.

Journal of acquired immune deficiency syndromes (1999)·2008

Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjects.

AIDS (London, England)·2006

T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimen.

The Journal of infectious diseases·2005

Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.

The Journal of infectious diseases·2004

Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection.

Journal of acquired immune deficiency syndromes (1999)·2003

See all related articles